Ranolazine for heart failure

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Aug 2024: Trial registered, NCT06570473
  2. 15 Jul 2025: Trial started, NCT06570473

The trials

NCT06570473: Feasibility Trial for a Right Ventricular Failure Platform Trial

State
Under way
Phase
Phase 2
People
30 planned
Started
15 Jul 2025
Primary completion
31 Mar 2027
Arms
Ranolazine
Results
None posted
  1. 26 Aug 2024: Trial registered
  2. 15 Jul 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Aspruzyo, Ranexa.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.